Skip to main content

EASD 58th Annual Meeting 2022

September 20 – September 23
EASD 2022 Annual Meeting news

Skin reactions rarely lead to diabetes device discontinuation

Skin reactions to glucose monitors and insulin pumps occur in more than a quarter of users but only occasionally result in device discontinuation, research shows.

EASD 2022 research news

09-23-2022 | EASD 2022 | Conference coverage | News

​​​​​​​Better diabetes self-care during adolescence could improve glycemic control trajectory

Among adolescents with type 1 diabetes, those with better self-care are more likely to have favorable glycated hemoglobin trajectories into early adulthood, study findings suggest.

09-23-2022 | EASD 2022 | Conference coverage | News

Topical esmolol hydrochloride may aid healing of diabetic foot ulcers

The use of esmolol hydrochloride in adults with diabetic foot ulcer improves wound healing and may constitute a novel treatment option, suggests research reported at the 58th EASD Annual Meeting in Stockholm, Sweden.

09-23-2022 | EASD 2022 | Conference coverage | News

ADA/EASD hyperglycemia management consensus update strengthens holistic care

The latest update to the ADA and EASD hyperglycemia management consensus report places a strong emphasis on holistic, person-centered care for type 2 diabetes.

09-23-2022 | EASD 2022 | Conference coverage | News

Degree of autoimmunity impacts CVD risk in LADA

09-21-2022 | EASD 2022 | Conference coverage | News

isCGM benefits sustained for at least 2 years